Medplus Health Services · NSE: MEDPLUS · BSE: 543427

Q1 FY25 results · Apr–Jun 2024

Medplus Health Services reported revenue from operations of ₹1,488.83 crore (up 15.9% from Q1 FY24) and net profit of ₹14.34 crore (up 281.0% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY25Q1 FY24YoYQ4 FY24QoQ
Revenue from operations1,488.831,284.30+15.9%1,490.50−0.1%
Other income8.719.39−7.3%10.46−16.7%
Total income1,497.541,293.69+15.8%1,500.96−0.2%
Profit before tax17.795.05+252.1%31.98−44.4%
Net profit for the period14.343.77+281.0%33.56−57.3%
Attributable to shareholders of the company14.363.79+279.4%33.40−57.0%
EPS, basic (₹)1.200.32+275.0%2.81−57.3%
Net margin (%)1.00.32.3
Standalone · ₹ crore
ItemQ1 FY25Q1 FY24YoYQ4 FY24QoQ
Revenue from operations178.3371.89+148.0%148.37+20.2%
Other income1.841.81+1.8%1.90−3.1%
Total income180.1773.70+144.5%150.27+19.9%
Profit before tax11.61(3.48)Turned profit6.32+83.6%
Net profit for the period9.26(3.48)Turned profit9.92−6.7%
EPS, basic (₹)0.77(0.29)Turned profit0.83−7.2%
Net margin (%)5.2-4.86.7
Consolidated
Filed with BSE
05 Aug 2024, 11:26 IST
Board meeting
02 Aug 2024
Period
01 Apr 2024 to 30 Jun 2024
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
05 Aug 2024, 11:26 IST
Board meeting
02 Aug 2024
Period
01 Apr 2024 to 30 Jun 2024
Review status
Audited
Source
XBRL filing on BSE